Seroatlas · Human Serome Atlas

E2F2

Transcription factor E2F2

Also known as: E2F-2, E2F2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q14209
Gene
E2F2
Ensembl
ENSG00000007968
Chromosome
1
Canonical length
437 aa
Protein class
Plasma proteins, Predicted intracellular proteins, Transcription factors

OverviewNCBI Gene

The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F1 and E2F3, have an additional cyclin binding domain. This protein binds specifically to retinoblastoma protein pRB in a cell-cycle dependent manner, and it exhibits overall 46% amino acid identity to E2F1. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

437 residues, UniProt reviewed canonical sequence.

>Q14209|E2F2
     1  MLQGPRALAS AAGQTPKVVP AMSPTELWPS GLSSPQLCPA TATYYTPLYP QTAPPAAAPG
    61  TCLDATPHGP EGQVVRCLPA GRLPAKRKLD LEGIGRPVVP EFPTPKGKCI RVDGLPSPKT
   121  PKSPGEKTRY DTSLGLLTKK FIYLLSESED GVLDLNWAAE VLDVQKRRIY DITNVLEGIQ
   181  LIRKKAKNNI QWVGRGMFED PTRPGKQQQL GQELKELMNT EQALDQLIQS CSLSFKHLTE
   241  DKANKRLAYV TYQDIRAVGN FKEQTVIAVK APPQTRLEVP DRTEDNLQIY LKSTQGPIEV
   301  YLCPEEVQEP DSPSEEPLPS TSTLCPSPDS AQPSSSTDPS IMEPTASSVP APAPTPQQAP
   361  PPPSLVPLEA TDSLLELPHP LLQQTEDQFL SPTLACSSPL ISFSPSLDQD DYLWGLEAGE
   421  GISDLFDSYD LGDLLIN

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against E2F2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.61
Highest tissue expression
24 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 24 nTPM
  • thymus: 15 nTPM
  • esophagus: 8.3 nTPM
  • spleen: 4.8 nTPM
  • testis: 3.4 nTPM
  • tonsil: 3.4 nTPM

Single-cell type

  • late spermatids: 33 nCPM
  • early spermatids: 5.4 nCPM
  • erythrocytes: 2.2 nCPM
  • erythrocyte progenitors: 0.8 nCPM
  • late primary spermatocytes: 0.8 nCPM
  • monocyte progenitors: 0.6 nCPM

Immune cell

  • basophil: 4.1 nTPM
  • T-reg: 1.3 nTPM
  • non-classical monocyte: 0.9 nTPM
  • eosinophil: 0.8 nTPM
  • intermediate monocyte: 0.6 nTPM
  • myeloid DC: 0.5 nTPM

Brain region

  • thalamus: 0.6 nTPM
  • cerebral cortex: 0.5 nTPM
  • choroid plexus: 0.5 nTPM
  • pons: 0.5 nTPM
  • white matter: 0.5 nTPM
  • amygdala: 0.4 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.56
gnomAD pLI
0.26
gnomAD missense Z
1
DepMap mean gene effect
-0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of E2F2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads E2F2 as an antibody target. Whether an autoantibody or antibody against E2F2 could matter depends on whether native E2F2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

E2F2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label E2F2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/E2F2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...